We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Lake Region Medical Joins with Greatbatch

By HospiMedica International staff writers
Posted on 07 Sep 2015
Medical technology company Greatbatch (Frisco, TX, USA) will buy privately owned Lake Region Medical (Wilmington, MA, USA), in a deal valued at about USD 1.73 billion in cash and stock.

Starting out as a fishing-lure company in 1947, Lake Region Medical found success in the 1960’s when the family-run operation began manufacturing tightly coiled wires for some of the earliest pacemakers made by Medtronic (Dublin, Ireland); it went on to develop offerings in electrophysiology, vascular access, urology, oncology, orthopedics, laparoscopy, arthroscopy, and other fields. More...
In March 2014, the company was acquired for USD 390 million by Accellent, a large supplier and strategic partner to the medical device industry, which changed its brand name to Lake Region Medical shortly after.

Greatbatch was founded by Wilson Greatbatch, who helped invent the first implantable pacemaker in 1961 and licensed it to Medtronic, whose own co-founder, Earl Bakken, had invented the first transistorized, wearable pacemaker four years earlier. Greatbatch went on to invent a lithium-iodine battery that greatly extended the life of pacemakers. The company now develops critical device technologies for cardiac, neuromodulation, vascular, and orthopedic markets, as well as batteries for high-end niche applications in the portable medical, energy, military, and environmental markets.

While the deal is slated to create one of the largest original equipment manufacturer (OEM) outsourcing companies for medical technology in the world, it will still have a share of only about 10%–12% of the highly fragmented industry. The combined entity will sell OEM parts and manufacturing solutions to major medical device companies for cardiac-rhythm management, neuromodulation, and vascular, orthopedic and surgical therapies, with operations in the United States, Latin America, Europe, and the Asia-Pacific region.

"The combination of Greatbatch and Lake Region Medical brings together two highly complementary organizations that can provide a new level of industry leading capabilities and services to OEM customers while building value for shareholders," said Thomas J. Hook, president and CEO of Greatbatch. “Through this transformative deal, we are going to be at the forefront of innovating technologies and products that help change the face of healthcare.”

“I am very proud of the Lake Region Medical team and what they have accomplished over many years,” said Donald Spence, CEO of Lake Region Medical. “I am confident the combination of Lake Region Medical and Greatbatch will form an even stronger entity with unmatched technology and manufacturing capabilities.”

Related Links:

Greatbatch
Lake Region Medical



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Hospital Stretcher
Millennium 5
New
Portable Digital Floor Scale
DR400C
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A mechanosensing-based approach offers a potential path to the treatment for cardiac fibrosis (Photo courtesy of Adobe Stock)

Mechanosensing-Based Approach Offers Promising Strategy to Treat Cardiovascular Fibrosis

Cardiac fibrosis, which involves the stiffening and scarring of heart tissue, is a fundamental feature of nearly every type of heart disease, from acute ischemic injuries to genetic cardiomyopathies.... Read more

Surgical Techniques

view channel
Image: Bioprinting synthetic vasculature could dramatically change how cardiovascular diseases are treated (Dell, A.C., Maresca, J., Davis, B.A. et al.; doi.org/10.1038/s41598-025-93276-y)

Bioprinted Aortas Offer New Hope for Vascular Repair

Current treatment options for severe cardiovascular diseases include using grafts made from a patient's own tissue (autologous) or synthetic materials. However, autologous grafts require invasive surgery... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.